Orphan drug logistics

buir.advisorYetiş, Bahar
dc.contributor.authorDursunoğlu, Çağla Fatma
dc.date.accessioned2020-08-27T11:18:27Z
dc.date.available2020-08-27T11:18:27Z
dc.date.copyright2020-07
dc.date.issued2020-07
dc.date.submitted2020-08-11
dc.descriptionCataloged from PDF version of article.en_US
dc.descriptionThesis (M.S.): Bilkent University, Department of Industrial Engineering, İhsan Doğramacı Bilkent University, 2020.en_US
dc.descriptionIncludes bibliographical references (leaves 88-93).en_US
dc.description.abstract"Orphan drugs" are medical products that are developed to treat orphan diseases. Since they are required by a small number of population, the pharmaceutical industry is not interested much in them. Hence they are produced in small amounts and they are difficult to attain. Moreover, patients may need them urgently. There are regulations for the transportation of orphan drugs to the patient. Those regulations differ among the countries. In this thesis, we focus on the logistics of the orphan drugs motivated by the application in Turkey. We analyze the implementation dynamics of Turkey and define related Operational Research (OR) problems. The overall problem can be considered as an application of locationrouting problem. We identify four performance measures based on urgency and ambulance scarcity. The primal aim in the current system is to serve the patient in need at short notice. Therefore, the minimization of the total distance is chosen to be the first performance measure. However, due to scarcity of ambulances in each city, the total extra disturbance, the maximum extra disturbance and the total number of cities disturbed are also analyzed. The problem includes multi-criteria optimization and the -constraint method is used to analyze the Pareto-optimal solutions. Turkey case is considered for computational analysis.en_US
dc.description.provenanceSubmitted by Betül Özen (ozen@bilkent.edu.tr) on 2020-08-27T11:18:27Z No. of bitstreams: 1 final form.pdf: 8886940 bytes, checksum: 324e8c8bd536b7e0d4f5fcc28770f007 (MD5)en
dc.description.provenanceMade available in DSpace on 2020-08-27T11:18:27Z (GMT). No. of bitstreams: 1 final form.pdf: 8886940 bytes, checksum: 324e8c8bd536b7e0d4f5fcc28770f007 (MD5) Previous issue date: 2020-08en
dc.description.statementofresponsibilityby Çağla Fatma Dursunoğluen_US
dc.format.extentxiii, 120 leaves : charts, color maps ; 30 cm.en_US
dc.identifier.itemidB160405
dc.identifier.urihttp://hdl.handle.net/11693/53950
dc.language.isoEnglishen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHealthcare systemsen_US
dc.subjectOrphan drugsen_US
dc.subjectMulti-criteria optimizationen_US
dc.subjectPareto analysisen_US
dc.titleOrphan drug logisticsen_US
dc.title.alternativeYetim İlaçların lojistiğien_US
dc.typeThesisen_US
thesis.degree.disciplineIndustrial Engineering
thesis.degree.grantorBilkent University
thesis.degree.levelMaster's
thesis.degree.nameMS (Master of Science)

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
final form.pdf
Size:
8.48 MB
Format:
Adobe Portable Document Format
Description:
Full printable version

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: